Issue navigation
Volume 61, Issue 11, November 2022
EDITORIALS
Getting it right for polymyalgia rheumatica
Rheumatology, Volume 61, Issue 11, November 2022, Pages 4221–4222, https://doi.org/10.1093/rheumatology/keac187
Safety of jakinibs: lessons from ORAL Surveillance
Rheumatology, Volume 61, Issue 11, November 2022, Pages 4223–4225, https://doi.org/10.1093/rheumatology/keac166
The need for clarity on the use of glucocorticoids for people with psoriatic arthritis: a call for consensus
Rheumatology, Volume 61, Issue 11, November 2022, Pages 4226–4228, https://doi.org/10.1093/rheumatology/keac366
SARS-CoV-2 vaccinations in children and adolescents with rheumatic diseases
Rheumatology, Volume 61, Issue 11, November 2022, Pages 4229–4231, https://doi.org/10.1093/rheumatology/keac431
SYSTEMATIC REVIEW AND META ANALYSIS
Systemic glucocorticoid use and the occurrence of flares in psoriatic arthritis and psoriasis: a systematic review
Rheumatology, Volume 61, Issue 11, November 2022, Pages 4232–4244, https://doi.org/10.1093/rheumatology/keac129
REVIEWS
Controversies in rheumatology: ultrasound for monitoring of RA—do we need it?
Rheumatology, Volume 61, Issue 11, November 2022, Pages 4245–4251, https://doi.org/10.1093/rheumatology/keac228
Increased risk of rheumatoid arthritis in patients with endometriosis: genetic aspects
Rheumatology, Volume 61, Issue 11, November 2022, Pages 4252–4262, https://doi.org/10.1093/rheumatology/keac143
CLINICAL SCIENCE
Safety and immunogenicity of BNT162b2 mRNA COVID-19 vaccine in adolescents with rheumatic diseases treated with immunomodulatory medications
Rheumatology, Volume 61, Issue 11, November 2022, Pages 4263–4272, https://doi.org/10.1093/rheumatology/keac103
Selection of treatment regimens based on shared decision-making in patients with rheumatoid arthritis on remission in the FREE-J study
Rheumatology, Volume 61, Issue 11, November 2022, Pages 4273–4285, https://doi.org/10.1093/rheumatology/keac075
Do patient-reported measures of disease activity in rheumatoid arthritis vary between countries? Results from a Nordic collaboration
Rheumatology, Volume 61, Issue 11, November 2022, Pages 4286–4296, https://doi.org/10.1093/rheumatology/keac081
The role of comorbidities alongside patient and disease characteristics in long-term disease activity in RA using UK inception cohort data
Rheumatology, Volume 61, Issue 11, November 2022, Pages 4297–4304, https://doi.org/10.1093/rheumatology/keac139
Implementation of the OMERACT Psoriatic Arthritis Magnetic Resonance Imaging Scoring System in a randomized phase IIb study of abatacept in psoriatic arthritis
Rheumatology, Volume 61, Issue 11, November 2022, Pages 4305–4313, https://doi.org/10.1093/rheumatology/keac073
Colchicine use and the risk of CKD progression: a multicentre nested case-control study
Rheumatology, Volume 61, Issue 11, November 2022, Pages 4314–4323, https://doi.org/10.1093/rheumatology/keac077
Ixekizumab in radiographic axial spondyloarthritis with and without elevated C-reactive protein or positive magnetic resonance imaging
Rheumatology, Volume 61, Issue 11, November 2022, Pages 4324–4334, https://doi.org/10.1093/rheumatology/keac104
High incidence of proliferative and membranous nephritis in SLE patients with low proteinuria in the Accelerating Medicines Partnership
Rheumatology, Volume 61, Issue 11, November 2022, Pages 4335–4343, https://doi.org/10.1093/rheumatology/keac067
Gene signature fingerprints stratify SLE patients in groups with similar biological disease profiles: a multicentre longitudinal study
Rheumatology, Volume 61, Issue 11, November 2022, Pages 4344–4354, https://doi.org/10.1093/rheumatology/keac083
Clonal haematopoiesis of indeterminate potential and cardiovascular events in systemic lupus erythematosus (HEMATOPLUS study)
Rheumatology, Volume 61, Issue 11, November 2022, Pages 4355–4363, https://doi.org/10.1093/rheumatology/keac108
Predictors of rituximab effect on modified Rodnan skin score in systemic sclerosis: a machine-learning analysis of the DesiReS trial
Rheumatology, Volume 61, Issue 11, November 2022, Pages 4364–4373, https://doi.org/10.1093/rheumatology/keac023
Gender- and age-specific rates of heart failure and other adverse cardiovascular outcomes in systemic sclerosis
Rheumatology, Volume 61, Issue 11, November 2022, Pages 4374–4383, https://doi.org/10.1093/rheumatology/keac072
Nailfold capillaroscopy in SSc: innocent bystander or promising biomarker for novel severe organ involvement/progression?
Rheumatology, Volume 61, Issue 11, November 2022, Pages 4384–4396, https://doi.org/10.1093/rheumatology/keac079
Dyspnoea and cough in patients with systemic sclerosis–associated interstitial lung disease in the SENSCIS trial
Rheumatology, Volume 61, Issue 11, November 2022, Pages 4397–4408, https://doi.org/10.1093/rheumatology/keac091
Cardiac magnetic resonance in systemic sclerosis myocarditis: the value of T2 mapping to detect myocardial inflammation
Rheumatology, Volume 61, Issue 11, November 2022, Pages 4409–4419, https://doi.org/10.1093/rheumatology/keac098
Chest MRI with CT in the assessment of interstitial lung disease progression in patients with systemic sclerosis
Rheumatology, Volume 61, Issue 11, November 2022, Pages 4420–4426, https://doi.org/10.1093/rheumatology/keac148
Biologic therapy in refractory neurobehçet’s disease: a multicentre study of 41 patients and literature review
Rheumatology, Volume 61, Issue 11, November 2022, Pages 4427–4436, https://doi.org/10.1093/rheumatology/keac097
Predictors of rapidly progressive interstitial lung disease and mortality in patients with autoantibodies against melanoma differentiation-associated protein 5 dermatomyositis
Rheumatology, Volume 61, Issue 11, November 2022, Pages 4437–4444, https://doi.org/10.1093/rheumatology/keac094
Branched chain amino acids in the treatment of polymyositis and dermatomyositis: a phase II/III, multi-centre, randomized controlled trial
Rheumatology, Volume 61, Issue 11, November 2022, Pages 4445–4454, https://doi.org/10.1093/rheumatology/keac101
Prevalence of frailty in patients with polymyalgia rheumatica and association with health-related quality of life, cognition and sarcopenia
Rheumatology, Volume 61, Issue 11, November 2022, Pages 4455–4464, https://doi.org/10.1093/rheumatology/keac050
Non-criteria manifestations in the presence of antiphospholipid antibodies in a paediatric cohort
Rheumatology, Volume 61, Issue 11, November 2022, Pages 4465–4471, https://doi.org/10.1093/rheumatology/keac070
Robust neutralizing antibody response to SARS-CoV-2 mRNA vaccination in adolescents and young adults with childhood-onset rheumatic diseases
Rheumatology, Volume 61, Issue 11, November 2022, Pages 4472–4481, https://doi.org/10.1093/rheumatology/keac105
Humoral response and safety of BNT162b2 mRNA vaccine in children with rheumatic diseases
Rheumatology, Volume 61, Issue 11, November 2022, Pages 4482–4490, https://doi.org/10.1093/rheumatology/keac140
Clinical worsening following discontinuation of tocilizumab in diffuse cutaneous systemic sclerosis: a single-centre experience in Japan
Rheumatology, Volume 61, Issue 11, November 2022, Pages 4491–4496, https://doi.org/10.1093/rheumatology/keac136
Myocardial fibrosis and arrhythmic burden in systemic sclerosis
Rheumatology, Volume 61, Issue 11, November 2022, Pages 4497–4502, https://doi.org/10.1093/rheumatology/keac065
Gastroparesis in systemic sclerosis: a detailed analysis using whole-gut scintigraphy
Rheumatology, Volume 61, Issue 11, November 2022, Pages 4503–4508, https://doi.org/10.1093/rheumatology/keac074
The performance of different classification criteria for systemic lupus erythematosus in a real-world rheumatology department
Rheumatology, Volume 61, Issue 11, November 2022, Pages 4509–4513, https://doi.org/10.1093/rheumatology/keac120
Efficacy and tolerance of corticosteroids and methotrexate in patients with juvenile dermatomyositis: a retrospective cohort study
Rheumatology, Volume 61, Issue 11, November 2022, Pages 4514–4520, https://doi.org/10.1093/rheumatology/keac107
BASIC SCIENCE
Glycine increased ferroptosis via SAM-mediated GPX4 promoter methylation in rheumatoid arthritis
Rheumatology, Volume 61, Issue 11, November 2022, Pages 4521–4534, https://doi.org/10.1093/rheumatology/keac069
TNFR2 is critical for TNF-induced rheumatoid arthritis fibroblast-like synoviocyte inflammation
Rheumatology, Volume 61, Issue 11, November 2022, Pages 4535–4546, https://doi.org/10.1093/rheumatology/keac124
Competitive binding of transcription factors underlies flexibility of T peripheral helper cells and T follicular helper cells in SLE
Rheumatology, Volume 61, Issue 11, November 2022, Pages 4547–4557, https://doi.org/10.1093/rheumatology/keac112
IL-25 participates in keratinocyte-driven dermal matrix turnover and is reduced in systemic sclerosis epidermis
Rheumatology, Volume 61, Issue 11, November 2022, Pages 4558–4569, https://doi.org/10.1093/rheumatology/keac044
Anti-Ro52 antibodies are associated with the prognosis of adult idiopathic inflammatory myopathy-associated interstitial lung disease
Rheumatology, Volume 61, Issue 11, November 2022, Pages 4570–4578, https://doi.org/10.1093/rheumatology/keac090
CORRECTIONS
Correction to: The impact of different (rheumatoid) arthritis phenotypes on patients’ lives
Rheumatology, Volume 61, Issue 11, November 2022, Page 4579, https://doi.org/10.1093/rheumatology/keac172
Correction to: Survival and associated comorbidities in inclusion body myositis
Rheumatology, Volume 61, Issue 11, November 2022, Page 4580, https://doi.org/10.1093/rheumatology/keac211
PUBLISHED ONLINE ONLY
LETTERS TO THE EDITOR
OTHER
COVID-19 mRNA vaccine booster in patients with autoimmune rheumatic diseases
Rheumatology, Volume 61, Issue 11, November 2022, Pages e328–e330, https://doi.org/10.1093/rheumatology/keac296
Changes to expert opinion in the use of antirheumatic drugs before and during pregnancy five years after EULAR: points to consider
Rheumatology, Volume 61, Issue 11, November 2022, Pages e331–e333, https://doi.org/10.1093/rheumatology/keac262
CASE REPORTS
Immunological changes and prevention of disease progression through elotuzumab therapy in refractory IgG4-related sclerosing mesenteritis
Rheumatology, Volume 61, Issue 11, November 2022, Pages e334–e336, https://doi.org/10.1093/rheumatology/keac302
An adult case of suspected A20 haploinsufficiency mimicking polyarteritis nodosa
Rheumatology, Volume 61, Issue 11, November 2022, Pages e337–e340, https://doi.org/10.1093/rheumatology/keac308
Successful remission with tofacitinib in a patient with refractory bullous systemic lupus erythematosus
Rheumatology, Volume 61, Issue 11, November 2022, Pages e341–e343, https://doi.org/10.1093/rheumatology/keac309
Etanercept for refractory chronic and deforming chikungunya polyarthritis: a case report
Rheumatology, Volume 61, Issue 11, November 2022, Pages e344–e345, https://doi.org/10.1093/rheumatology/keac313
MATTERS ARISING
Comment on: Survival and associated comorbidities in inclusion body myositis
Rheumatology, Volume 61, Issue 11, November 2022, Pages e346–e347, https://doi.org/10.1093/rheumatology/keac378
Comment on: Survival and associated comorbidities in inclusion body myositis: Reply
Rheumatology, Volume 61, Issue 11, November 2022, Pages e348–e349, https://doi.org/10.1093/rheumatology/keac379
CLINICAL VIGNETTES
Musculoskeletal manifestations of leprosy
Rheumatology, Volume 61, Issue 11, November 2022, Pages e350–e351, https://doi.org/10.1093/rheumatology/keac189
Tumefactive lesion revealing neuro-Behçet’s disease
Rheumatology, Volume 61, Issue 11, November 2022, Pages e352–e353, https://doi.org/10.1093/rheumatology/keac194
A giant coronary artery aneurysm in a patient with Behçet’s syndrome
Rheumatology, Volume 61, Issue 11, November 2022, Pages e354–e355, https://doi.org/10.1093/rheumatology/keac265
Albright’s hereditary osteodystrophy: an entity to recognize
Rheumatology, Volume 61, Issue 11, November 2022, Pages e356–e357, https://doi.org/10.1093/rheumatology/keac277
